Companies: 10,795·Total market cap: $144.5T

Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUGNASDAQHealthcare● Active

$65.28

$-3.72(-5.39%)

Market Cap$506671699

P/E Ratio—

52W High$123.75

52W Low$23.175

Avg Volume209K

Open$70.03

Beta-0.11

Net Income Financials Revenue

Bright Minds Biosciences Inc. (DRUG) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

DRUG · net income · updated Jun 9, 2026

Core profitability metrics

DRUG · net income · margin · TTM · CAGR

Net income was −$12.2M for FY2025 (fiscal year ending 2025-09-30), down 336.5% year-over-year. Net profit margin was —.

FY2025 Net Income−$12.2M▼ -336.5% YoY

Trailing 12M (TTM)−$27.5Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-336.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · DRUG net income history · DRUG profit margin

Annual net income data

DRUG · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$12.2M▼ 336.5%—$0

FY2024Loss−$2.8M▲ +62.0%—$0

FY2023Loss−$7.4M▲ +50.7%—$0

FY2022Loss−$15.0M▼ 73.0%—$0

FY2021Loss−$8.7M▼ 1700.8%—$0

Net income vs peers (Healthcare)

DRUG vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Bright Minds Biosciences Inc.YOU

DRUG

−$12.2M-336.5%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Bright Minds Biosciences Inc. (DRUG) reported net income of −$12.2M for FY2025 (fiscal year ending 2025-09-30), down 336.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Bright Minds Biosciences Inc. has not yet achieved annual profitability based on available data (7 fiscal years). The company has reported net losses across all available periods.

Bright Minds Biosciences Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Bright Minds Biosciences Inc. net worth" — the company's market capitalization is a separate figure from DRUG net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

DRUG net income · 4 questions

Bright Minds Biosciences Inc. is not currently profitable on an annual basis. The company reported a net loss of $12.2M for FY2025.

is DRUG profitabledoes DRUG make a profitDRUG profitabilityDRUG profitable company

▸ Source: FMP /income-statement · GAAP · Bright Minds Biosciences Inc. · Bright Minds Biosciences Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026